Brief: Eledon Pharmaceuticals Posts Q3 Loss Per Share Of $0.66
Nov 11 (Reuters) - Eledon Pharmaceuticals Inc ELDN.O :
* ELEDON PHARMACEUTICALS REPORTS THIRD QUARTER 2021
OPERATING AND
FINANCIAL RESULTS
* Q3 LOSS PER SHARE $0.66
* Q3 EARNINGS PER SHARE VIEW $-0.65 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX35hqdh
Further company coverage: ELDN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial